Follow us:
DKMG EGFRvIII cell line
You are here   PRODUCTS >> CELL LINES >> GENETICALLY MODIFIED CELL LINES >> DKMG/EGFRvIII
DKMG/EGFR vIII
Celther Catalogue Number:  
CL 01008-CLTH

Organism: 
Homo sapiens, human

Tissue:  
Brain

Disease:  
Glioblastoma

Growth Properties:  
Adherent

Biosafety Level:  
1

Product Format:  
frozen 1 mL, 1x106 cells/vial

Regulatory Statement:  

For Research Use Only. Not for use in diagnostic procedures.


Comment:  

Application of the DKMG/EGFRvIII cell line opens new perspectives in EGFRvIII research. EGFRvIII expression was reinduced in cells, which expressed EGFRvIII in vivo, but due to unknown reasons did not in vitro. DKMG cells show mutation at DNA level, which is responsible for the expression of EGFRvIII mRNA and protein, however, in most of these cells the expression of mutatant EGFR gene copies is silenced (these cells show the amplification of this gene). The performed biotechnological modification results in the EGFRvIII expression in all cells of the DKMG cell line.
COPYRIGHT © 2017 CELTHER POLSKA